NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 37.76 | 40.88 | 34.52 | 41.88 | -1.51 |
| CEPS(Rs) | 38.55 | 41.77 | 35.58 | 44.34 | 2.40 |
| DPS(Rs) | - | 25.00 | 25.00 | 47.50 | 10.00 |
| Book NAV/Share(Rs) | 331.37 | 318.06 | 301.79 | 314.30 | 281.17 |
| Tax Rate(%) | 28.14 | 22.63 | 30.65 | 10.42 | 2.62 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.96 | 23.44 | 17.79 | 15.74 | 5.50 |
| EBIT Margin(%) | 34.73 | 33.63 | 33.89 | 28.33 | 0.21 |
| Pre Tax Margin(%) | 34.40 | 33.43 | 33.49 | 27.90 | -0.78 |
| PAT Margin (%) | 24.72 | 25.87 | 23.22 | 25.00 | -0.76 |
| Cash Profit Margin (%) | 25.24 | 26.43 | 23.93 | 26.46 | 1.22 |
| Performance Ratios | |||||
| ROA(%) | 4.80 | 5.35 | 4.35 | 5.09 | -0.18 |
| ROE(%) | 11.63 | 13.19 | 11.21 | 14.07 | -0.53 |
| ROCE(%) | 16.34 | 17.15 | 16.35 | 15.96 | 0.14 |
| Asset Turnover(x) | 0.19 | 0.21 | 0.19 | 0.20 | 0.23 |
| Sales/Fixed Asset(x) | 40.86 | 20.84 | 10.90 | 10.39 | 8.43 |
| Working Capital/Sales(x) | 0.60 | 0.65 | 0.68 | 0.80 | 0.99 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.02 | 0.05 | 0.09 | 0.10 | 0.12 |
| Receivable days | 37.37 | 38.18 | 38.62 | 35.62 | 31.23 |
| Inventory Days | 45.72 | 40.22 | 49.54 | 49.34 | 39.38 |
| Payable days | 97.63 | 101.73 | 110.74 | 119.32 | 130.52 |
| Valuation Parameters | |||||
| PER(x) | 25.71 | 19.20 | 29.80 | 13.50 | - |
| PCE(x) | 25.19 | 18.79 | 28.91 | 12.75 | 245.74 |
| Price/Book(x) | 2.93 | 2.47 | 3.41 | 1.80 | 2.10 |
| Yield(%) | - | 3.18 | 2.43 | 8.40 | 1.69 |
| EV/Net Sales(x) | 4.88 | 3.62 | 5.80 | 2.22 | 2.35 |
| EV/Core EBITDA(x) | 13.01 | 9.67 | 15.30 | 6.81 | 15.58 |
| EV/EBIT(x) | 13.20 | 9.83 | 15.62 | 7.16 | 930.30 |
| EV/CE(x) | 2.11 | 1.64 | 2.61 | 1.08 | 1.36 |
| M Cap / Sales | 6.76 | 5.44 | 7.58 | 3.68 | 3.64 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -0.54 | 6.33 | -11.53 | -5.28 | 4.86 |
| Core EBITDA Growth(%) | -0.38 | 5.07 | 3.04 | 104.30 | 0.70 |
| EBIT Growth(%) | -0.21 | 5.52 | 6.15 | - | -97.88 |
| PAT Growth(%) | -7.65 | 18.44 | -17.58 | 2,878.49 | -117.80 |
| EPS Growth(%) | -7.65 | 18.44 | -17.58 | 2,878.48 | -117.80 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.45 | 2.42 | 2.36 | 2.93 | 2.47 |
| Quick Ratio(x) | 2.32 | 2.32 | 2.24 | 2.73 | 2.30 |
| Interest Cover(x) | 103.90 | 170.38 | 83.44 | 66.93 | 0.21 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹4,860.6 Cr | 0.3% | 24.2% | 116.7% | Stock Analytics | |
| ADANI ENTERPRISES | ₹382,332.0 Cr | -3.1% | -1.4% | 16.2% | Stock Analytics | |
| AEGIS LOGISTICS | ₹49,166.3 Cr | 2.5% | 14.8% | 78.4% | Stock Analytics | |
| ADITYA INFOTECH | ₹46,587.2 Cr | 2.9% | 2% | 190.3% | Stock Analytics | |
| PREMIER ENERGIES | ₹39,800.2 Cr | -2.4% | -13.5% | -16.8% | Stock Analytics | |
| REDINGTON | ₹31,099.0 Cr | -2.3% | 13.9% | 51.7% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 0.3% |
24.2% |
116.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses
